Selected Publications

08/24/10: Health Benefits from Tea: Perception vs. Reality

WellGen’s own Dr. Shiming Li presented research about the analytical method for measuring polyphenols and the polyphenol content in ready-to-drink tea beverages at the American Chemical Society (ACS) meeting that began August 22 [...]

Alignomx

Using the science of nutrigenomics WellGen has developed the Alignomx™ model, a proprietary bioinformatics model that uses gene expression data to determine optimal therapeutic areas for WellGen’s pipeline of proprietary natural products.

Clinical support for WellGen^® theaflavin- rich black tea concentrate:

Human Clinical Study 1:

Systemic Inflammation Study LPS (lipopolysaccharide)- mediated challenge exposes the inflammation cascade and is a fundamental pharmaceutical inflammation probe.

Key findings

• Reduces expression of pro-inflammatory mRNA and cytokines/chemokines proteins
• Inflammatory biomarker levels ranging between two-to-four fold less than the placebo group
• Elevation of immuno-modulatory cytokine IL-10

Human Clinical Study 2:

Exercise-induced Inflammation - Test the effects in high-intensity anaerobic exercise on:

• Delayed onset muscle soreness (DOMS)
• Oxidative stress
• Cortisol response
• Inflammatory biomarkers

Key findings

• Reduces damage and inflammation due to exercise related stress
• Promotes rapid post-exercise recovery
• Improves capacity to exercise
• Reduces oxidative stress markers
• Relieves delayed onset muscle soreness due

© 2012 WellGen Inc. | 330 Madison Avenue, 31st Floor | New York, New York 10017 | Phone: 212.210.6282
Home | About Us | Research | Business Development | Investors | Contact Us | Terms and Conditions